 |
市場調査レポート
商品コード
1085809
がん細胞の世界市場：がん細胞タイプ、用途、エンドユーザー、地域別 - 規模、シェア、見通し、機会分析（2022年～2028年）Cancer Cell Market, by Cancer Cell Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
価格
| がん細胞の世界市場：がん細胞タイプ、用途、エンドユーザー、地域別 - 規模、シェア、見通し、機会分析（2022年～2028年） |
|
出版日: 2022年05月15日
発行: Coherent Market Insights
ページ情報: 英文 175 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
概要
当レポートでは、世界のがん細胞市場について調査分析し、市場概要、市場力学、動向、競合情勢、企業プロファイルなど、体系的な情報を提供しています。
目次
第1章 調査目的・前提条件
第2章 市場の展望
- レポート説明
- 市場の定義と範囲
- エグゼクティブサマリー
- 市場スナップショット：がん細胞タイプ別
- 市場スナップショット：用途別
- 市場スナップショット：エンドユーザー別
- 市場スナップショット：地域別
- コヒーレントオポチュニティマップ（COM）
第3章 市場力学・規制・動向分析
- 促進要因
- 抑制要因
- 市場機会
- 影響分析
- 主な発展
- 新製品の発売・承認
- 合併・買収シナリオ
- 規制シナリオ
- パイプライン分析
- 疫学
- PEST分析
- 償還
第4章 世界のがん細胞市場：コロナウイルス（COVID-19）パンデミックの影響
- COVID-19対処に向けた政府のイニシアチブ
- がん患者に対するCOVID-19の影響
- 腫瘍治療に対するCOVID-19の影響
第5章 世界のがん細胞市場：がん細胞タイプ別（2017年～2028年）
- イントロダクション
- 市場シェア分析：2022年・2028年
- 前年比成長分析：2017年～2028年
- セグメント動向
第6章 世界のがん細胞市場：用途別（2017年～2028年）
- イントロダクション
- 市場シェア分析：2022年・2028年
- 前年比成長分析：2017年～2028年
- セグメント動向
第7章 世界のがん細胞市場：エンドユーザー別（2017年～2028年）
- イントロダクション
- 市場シェア分析：2022年・2028年
- 前年比成長分析：2017年～2028年
- セグメント動向
第8章 世界のがん細胞市場：地域別（2017年～2028年）
- イントロダクション
- 市場シェア分析：国別（2022年・2028年）
- 前年比成長分析：国別（2017～2028年）
- 北米
- イントロダクション
- 市場規模と予測：がん細胞タイプ別（2017年～2028年）
- 市場規模と予測：用途別（2017年～2028年）
- 市場規模と予測：エンドユーザー別（2017年～2028年）
- 市場規模と予測：国別（2017年～2028年）
- ラテンアメリカ
- イントロダクション
- 市場規模と予測：がん細胞タイプ別（2017年～2028年）
- 市場規模と予測：用途別（2017年～2028年）
- 市場規模と予測：エンドユーザー別（2017年～2028年）
- 市場規模と予測：国別（2017年～2028年）
- 欧州
- イントロダクション
- 市場規模と予測：がん細胞タイプ別（2017年～2028年）
- 市場規模と予測：用途別（2017年～2028年）
- 市場規模と予測：エンドユーザー別（2017年～2028年）
- 市場規模と予測：国別（2017年～2028年）
- アジア太平洋
- イントロダクション
- 市場規模と予測：がん細胞タイプ別（2017年～2028年）
- 市場規模と予測：用途別（2017年～2028年）
- 市場規模と予測：エンドユーザー別（2017年～2028年）
- 市場規模と予測：国別（2017年～2028年）
- 中東
- イントロダクション
- 市場規模と予測：がん細胞タイプ別（2017年～2028年）
- 市場規模と予測：用途別（2017年～2028年）
- 市場規模と予測：エンドユーザー別（2017年～2028年）
- 市場規模と予測：国別（2017年～2028年）
- アフリカ
- イントロダクション
- 市場規模と予測：がん細胞タイプ別（2017年～2028年）
- 市場規模と予測：用途別（2017年～2028年）
- 市場規模と予測：エンドユーザー別（2017年～2028年）
- 市場規模と予測：国/地域別（2017年～2028年）
第9章 競合情勢
- 企業プロファイル
- Abbott Laboratories
- Novartis International AG
- Arcellx
- Autolus Therapeutics
- Kite Pharma
- Cellectis
- Celyad Oncology
- Crescendo Biologics Limited
- GammaDelta Therapeutics Ltd.
- Bio-Rad Laboratories Inc
- QIAGEN Inc
- Thermo Fisher Scientific
- Merck Millipore
- Siemens Healthineers AG
- GE Healthcare
目次
Product Code: CMI4338
The global cancer cell market include various therapies used for the treatment of various cancers such as lung cancer, breast cancer, and others. There are various therapies for treatment of cancer such as chemotherapy, radiation therapy, immunotherapy, hormone therapy, targeted drug therapy and others. The types of cancer such as carcinomas, sarcomas, leukemia, and others are caused due day to day lifestyles, and or more often, caused by carcinogens (cancer causing substances) such as tobacco etc.
Market Dynamics
Key players are focusing on research and development for treatment of cancers such as small cell lung cancer to strengthen their position in the global cancer cell market. For instance, in December 2019, Roche announced that the U.S. Food and Drug Administration (FDA) approved its Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane) for the initial (first-line) treatment of adults with metastatic non-squamous non-small cell lung cancer (NSCLC) with no epidermal growth factor receptor (EGFR) mutations and anaplastic large-cell lymphoma kinase (ALK) genomic tumor aberrations.
Key features of the study:
- This report studies the current scenario as well as the future potential of the global cancer cell market. The market for cancer cell market is segmented on basis of cancer cell type, application, end user, and region.
- This report provides in-depth analysis of the global cancer cell market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2022-2028), considering 2021 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
- It profiles leading players in the global cancer cell market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
- Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
- The global cancer cell market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
- Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global cancer cell market
Detailed Segmentation:
- Global Cancer Cell Market, By Cancer Cell Type:
- Carcinomas
- Sarcomas
- Leukemia
- Others
- Global Cancer Cell Market, By Application:
- Chemotherapy.
- Radiation Therapy
- Immunotherapy
- Hormone Therapy
- Targeted Drug Therapy
- Others
- Global Cancer Cell Market, By End User :
- Hospitals & Clinics
- Specialty Clinics
- Diagnostic Laboratories
- Global Cancer Cell Market, By Region:
- North America
- By Cancer Cell Type:
- Carcinomas
- Sarcomas
- Leukemia
- Others
- By Application:
- Chemotherapy.
- Radiation Therapy
- Immunotherapy
- Hormone Therapy
- Targeted Drug Therapy
- Others
- By End User :
- Hospitals & Clinics
- Specialty Clinics
- Diagnostic Laboratories
- By Country:
- U.S.
- Canada
- Latin America
- By Cancer Cell Type:
- Carcinomas
- Sarcomas
- Leukemia
- Others
- By Application:
- Chemotherapy.
- Radiation Therapy
- Immunotherapy
- Hormone Therapy
- Targeted Drug Therapy
- Others
- By End User :
- Hospitals & Clinics
- Specialty Clinics
- Diagnostic Laboratories
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Cancer Cell Type:
- Carcinomas
- Sarcomas
- Leukemia
- Others
- By Application:
- Chemotherapy.
- Radiation Therapy
- Immunotherapy
- Hormone Therapy
- Targeted Drug Therapy
- Others
- By End User :
- Hospitals & Clinics
- Specialty Clinics
- Diagnostic Laboratories
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Cancer Cell Type:
- Carcinomas
- Sarcomas
- Leukemia
- Others
- By Application:
- Chemotherapy.
- Radiation Therapy
- Immunotherapy
- Hormone Therapy
- Targeted Drug Therapy
- Others
- By End User :
- Hospitals & Clinics
- Specialty Clinics
- Diagnostic Laboratories
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Cancer Cell Type:
- Carcinomas
- Sarcomas
- Leukemia
- Others
- By Application:
- Chemotherapy.
- Radiation Therapy
- Immunotherapy
- Hormone Therapy
- Targeted Drug Therapy
- Others
- By End User :
- Hospitals & Clinics
- Specialty Clinics
- Diagnostic Laboratories
- By Country/Region:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Cancer Cell Type:
- Carcinomas
- Sarcomas
- Leukemia
- Others
- By Application:
- Chemotherapy.
- Radiation Therapy
- Immunotherapy
- Hormone Therapy
- Targeted Drug Therapy
- Others
- By End User :
- Hospitals & Clinics
- Specialty Clinics
- Diagnostic Laboratories
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- Abbott Laboratories.*
- Company Overview
- Material Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- Novartis International AG
- Arcellx
- Autolus Therapeutics
- Kite Pharma
- Cellectis
- Celyad Oncology
- Crescendo Biologics Limited
- GammaDelta Therapeutics Ltd.
- Bio-Rad Laboratories Inc
- QIAGEN Inc
- Thermo Fisher Scientific
- Merck Millipore
- Siemens Healthineers AG
- GE Healthcare
- Abbott Laboratories.*
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Cancer Cell Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Key Developments
- New Product Launches/Approvals
- Merger-Acquisition Scenario
- Regulatory Scenario
- Pipeline Analysis
- Epidemiology
- PEST Analysis
- Reimbursement
4. Global Cancer Cell Market - Impact of Coronavirus (COVID-19) Pandemic
- Government Initiative To Combat Covid-19
- COVID 19 Impact on Cancer Patients
- COVID 19 Impact on Oncology Treatment
5. Global Cancer Cell Market, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Carcinomas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Sarcomas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Leukemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. Global Cancer Cell Market, By Application, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Chemotherapy.
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Radiation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Hormone Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Targeted Drug Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. Global Cancer Cell Market, By End User, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
8. Global Cancer Cell Market, By Region, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Countries, 2017 - 2028
- North America
- Introduction
- Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
- South Africa
- Central Africa
- North Africa
9. Competitive Landscape
- Company Profiles
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis International AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Arcellx
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Autolus Therapeutics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Kite Pharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cellectis
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Celyad Oncology
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Crescendo Biologics Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GammaDelta Therapeutics Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bio-Rad Laboratories Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- QIAGEN Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Thermo Fisher Scientific
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck Millipore
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Siemens Healthineers AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GE Healthcare
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
